
Blaze Systems
Investors Count
1Funding, Valuation & Revenue
1 Fundings
Blaze Systems's latest funding round was a Incubator/Accelerator for on .
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
Incubator/Accelerator |
Date | |
---|---|
Round | Incubator/Accelerator |
Amount | |
Investors | |
Valuation | |
Revenue | |
Sources |
Blaze Systems Investors
1 Investors
Blaze Systems has 1 investors. Delaware Technology Park invested in Blaze Systems's Incubator/Accelerator funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
1 Incubator/Accelerator | Incubator/Accelerator | Delaware |
First funding | |
---|---|
Last Funding | |
Investor | |
Rounds | 1 Incubator/Accelerator |
Board Seats | |
Type | Incubator/Accelerator |
Location | Delaware |
Compare Blaze Systems to Competitors

Plexus Ventures is a healthcare advisory boutique operating in the healthcare, pharma, medical devices, biotech, and consumer health sectors. The company offers strategic advisory services, managing long and time-consuming transactions, and provides structure to corporate and business development activities. Primarily, Plexus Ventures caters to healthcare companies of all sizes worldwide. It is based in Santa Monica, California.
Integrated Biosystems (Napa, CA) is the world's leading supplier of controlled freeze and thaw technologies for storage and transport of specialized biopharmaceuticals. Integrated Biosystems, Inc. was acquired by Stedim S.A. (Euronext Paris: DIM).
Laureate Pharma is a company focused on the healthcare and pharmaceutical industry. It provides a range of services including the synthesis of pharmaceutical substances, the creation of finished dosage forms, and the development and launch of pulmonary drugs. The company primarily sells to the healthcare sector, with a focus on pharmacies and other pharmaceutical companies. It is based in Princeton, New Jersey.
MOgene LC is a company that focuses on providing genomic services, operating within the biopharma and agritech industries. The company offers a range of services including genomic sequencing and bioinformatics, aimed at delivering precise research and clinical insights. Its primary customer segments include the agriculture, pharmaceutical, and industrial biotech industries. It was founded in 2004 and is based in St. Louis, Missouri.
AthenaES specializes in the development and commercialization of advanced biotechnology-based products. Throughout its eleven year history, the company has maintained a broad perspective for applying its core competency, the use of proteins and enzymes for commercial applications, to develop products. As such, the company currently markets its products and services through two business units and maintains an exploratory R&D group. The Athena Enzyme Systems Group aims to provide specialty reagents and proteins for the production and recovery of recombinant proteins along with providing contract R&D services. Products include: Expression Media, Serum-free Media, Protein Refolding kits, and the PDQ Protease Assay. This business unit also aims to provide specialized contract research, development and manufacturing services for the production of recombinant proteins. The Athena Environmental Services Group designs, develops and manufactures environmentally responsible products. Products developed include: The Bilge Pill, a biodegradable cleaning product for the removal of oil in boat bilges, and a plant nutrient supplement used in hydroponics, hobby gardens and horticulture that replaces conventional fertilizers, and the Sting Thing, an enzyme-based invertebrate sting treatment product. More recently, this group developed and has introduced a water-soluble, reversible glue, MagiGlue. The Athena Exploratory Science Group has the mission to pursue research with the potential for commercial, environmental and social impact. These projects are far reaching in their scope and represent high risk, high-value projects.
Spreading innovation in the Nano- and Biotechnology fields - this is the aim of Tethis. The company are heading for this goal through a tri-fold market approach reflected by the three business units of Tethis: Tethis Systems, Tethis Technology Services and Tethis Research. Tethis Systems focuses on the design and sale of nanoparticle synthesis and nanocoating units allowing customers to develop their own nanotech-products in-house. Tethis Technology Services supports customers with nano - and biotech product development by technical consulting and by opening Tethis' platform technologies for services such as tailor-made coatings or nanopowder development. Tethis Research targets on the incorporation of nanotechnology in devices, for instance by the integration of nanotechnology, biotechnology and microfabrication. Many of the company's research projects are based on collaborations with industries, universities and research centers reflecting the company's motto "Integration through collaboration".n
Loading...